Bristol Myers Gets Speedy FDA Review of Opdivo/Yervoy Combo in Certain Colorectal Cancer Patients
Bristol Myers said about 5% to 7% of people with metastatic colorectal cancer have microsatellite instability-high or mismatch-repair-deficient tumors, adding that these patients are less likely to ...
XORTX Commences Gout Program NDA Discussions with the FDA
Type C Meeting Requested to Accelerate XRx-026 for Gout to NDA ● CALGARY, Alberta, Feb. 24, 2025 (GLOBE NEWSWIRE) -- XORTX ...
The Royal Gazette2h
BTA weighs public interest on release of settlement data
A decision has yet to be made by the Bermuda Tourism Authority on whether access to information about spending on any ...
capitalbrief11h
Neuren shares climb on fresh FDA designation
Neuren Pharmaceuticals was among the best-performing ASX 200 stocks in morning trade after securing a rare pediatric disease ...
Premium economy versus budget business class: What you get for the money
Premium economy on full-service airlines can be expensive, but is travelling in a budget airline’s “business” class a worthy ...